Clinical Trial Update: Functional Magnetic Resonance Imaging and 1H-Nuclear Magnetic Resonance Spectroscopic Imaging in Treating Patients With Newly Diagnosed Brain Tumors [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating functional MRI and 1H-NMR spectroscopic imaging for newly diagnosed brain tumors has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Neoplasms

Snippet

Sponsor: Jonsson Comprehensive Cancer Center | Conditions: Brain and Central Nervous System Tumors | Phase 2 | Status: WITHDRAWN